Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-08-10
1998-10-27
Smith, Lynette F.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 723, 435 76, 435 79, 530350, G01N 3353, G01N 33574, C07K 100, C07K 1400
Patent
active
058276661
ABSTRACT:
The present invention relates to novel synthetic muc-1 peptides and muc-1-like analogs including at least two 20-amino acid tandem repeats of muc-1, which synthetic muc-1 and muc-1-like peptides are capable of attaining native conformation in the absence of glycosylation. The invention also relates to methods of producing the peptides. The invention further relates to uses of the peptides, such as for vaccines and diagnostic testing.
REFERENCES:
Gendler et al, 1988, "A Highly Immunogenic Region . . . " J. Biol. Chem. 263(26):12820-12823.
Bara, et al, 1993, "A Fucose Residue can Mask . . . " International J. Cancer 54:607-613.
von Mensdorff-Pouilly et al., "Cancer Vaccines, 1996-Oct. 7-9, 1996, N.Y. Humoral Immune Response to Polymeric Epithelial Mucin . . . Tumors".
Petrarca, et al. -"Human Anti-Pem (Polymorphic Epithelial Mucin) Antinbodies Production by B Lymphocytes Selected From . . . Nodes".
McGuckin, et al.-"Antibodies Reactive with the MUC1 VNTR are Present in Ovarian Cancer Patients and Healthy Women".
Carol Clayberger et al., Peptides Corresponding to the CD8 and CD4 Binding Domains of HLA Molecules Block T Lymphocyte Immune Responses In Vitro.sup.1, pp. 946-951.
Alessandro Sette et al., Peptide Binding To The Most Frequent HLA-A Class I Alleles Measured By Quantitative Molecular Binding Assays, pp. 813-822.
Niklas Ahlborg et al., "B- and T-cell responses in congenic mice to repeat sequences of the malaria antigen Pf332: effects of the number of repeats", Imunology Letters, 40 (1994) 147-155.
Michael N. Starnbach et al., Cells Infected with Yersinia Present an Epitope to Class I MHC-Restricted CTL.sup.1, The Journal of Immunology, pp. 1603-1612.
Thronsten Vogel et al., The Majority of Neutralizing Abs in HIV-1-Infected Patients Linear V3 Loop Sequences, (1994) The Journal of Immunology, pp. 1895-1904.
Ichiro Yoshino et al., "HER2
eu-derived Peptides Are Shared Antigens among Human Non-Small Cell Lung Cancer and Ovarian Cancer", Cancer Research 54 3387-3390, Jul. 1, 1994.
Jean-Pierre Cabaniols et al., "Dose-dependent T cell tolerance to an immunodominant self peptide", Eur. J. Immunol. 1994 24: 1743-1749.
Gilles Benichou et al., "Limited T Cell Response to Donor MHC Peptides During Allograft Rejection", The Journal of Immunology, pp. 938-945.
Isao Nishimori et al., "Influence of Acceptor Substrate Primary . . . N-Acetylgalactosaminyltransferase", The Journal of Biological Chemistry, Vo. 269, No. 23, Jun. 10, pp. 16123-16130, 1994.
Hareuveni et al., "Vaccination against tumor cells expressing breast cancer epithelial tumor antigen", Proc. Natl. Acad. Sci. USA, vol. 87, pp. 9498-9502, Dec. 1990, Medical Sciences.
Acres et al., "Vaccinia Virus MUC1 . . . Antigen", Journal of Immunotherapy, 14:136-143, 1993.
Ding et al., "Immunogenicity of synthetic peptides . . . MUC1 gene", Cancer Immunol Immunother (1993), 36: 9-17.
Abstract - "Mucin Based Immunity and Immunotheraphy of Cancer", by O.J. Finn, Dept. of Molecular Genetics and Biochemisty, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
J. Darrell Fontenot, et al., Biophysical Characterization of One-, Two-, and Three-Tandem Repeats of Human Mucin (muc-1) Protein Core.sup.1, Cancer Research 53, 5386-5394, Nov. 15, 1993.
J. D. Fontenot, et al., Synthesis of Large Multideterminant Peptide Immunogens Using A poly-Proline .beta.-Turn Helix Motiff, Peptide Research, 330-336, vol. 6, No. (1993).
Yasuo Kotera, et al., Humoral Immunity against a Tandem Repeat Epitope of Human Mucin MUC-1 in Sera From Breast, Pancreatic, and Colon Cancer Patients.sup.1, Advances in Brief, Cancer Research 54, 2856-2860, Jun. 1, 1994.
Olivera J. Finn, Antigen-specific, MHC-unrestricted T cells, Biotherapy 4: 239-249, 1992, Dept. of Molecular Genetics and Biochemisty, University of Pittsburg School of Medicine, Pittsburgh, PA 15261, USA.
Finn Olivera J.
Fontenot J. Darrell
Montelaro Ronald C.
Smith Lynette F.
University of Pittsburgh
LandOfFree
Synthetic multiple tandem repeat mucin and mucin-like peptides, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic multiple tandem repeat mucin and mucin-like peptides, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic multiple tandem repeat mucin and mucin-like peptides, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1612962